Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1977 1
1978 3
1981 4
1983 1
1985 1
1986 1
1988 3
1989 4
1990 5
1991 7
1992 1
1993 3
1994 3
1996 2
1998 4
1999 1
2000 3
2001 1
2002 4
2003 5
2004 1
2005 6
2006 5
2007 3
2008 1
2010 2
2011 7
2012 4
2013 1
2014 6
2015 1
2016 1
2017 1
2018 1
2019 6
2020 1
2021 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

101 results

Results by year

Filters applied: . Clear all
Page 1
Les études post-inscriptions en France, quels enjeux pour les dispositifs médicaux.
Levesque K, Coqueblin C, Guillot B; et les participants à la table ronde N°3 de Giens XXIX; Aubourg L, Avouac B, Carbonneil C, Cucherat M, Descamps-Mandine P, Hanoka S, Goldberg M, Josseran A, Parquin F, Pitel S, Ratignier C, Sechoy O, Szwarcenstein K, Tanti A, Teiger E, Thevenet N. Levesque K, et al. Among authors: avouac b. Therapie. 2014 Jul-Aug;69(4):303-12. doi: 10.2515/therapie/2014047. Therapie. 2014. PMID: 27393225 French. No abstract available.
Precision oncology: a clinical and patient perspective.
Lassen UN, Makaroff LE, Stenzinger A, Italiano A, Vassal G, Garcia-Foncillas J, Avouac B. Lassen UN, et al. Among authors: avouac b. Future Oncol. 2021 Oct;17(30):3995-4009. doi: 10.2217/fon-2021-0688. Epub 2021 Jul 19. Future Oncol. 2021. PMID: 34278817 Free article. Review.
Ketoprofen: the European experience.
Avouac B, Teule M. Avouac B, et al. J Clin Pharmacol. 1988 Dec;28(s1):S2-7. doi: 10.1002/j.1552-4604.1988.tb05972.x. J Clin Pharmacol. 1988. PMID: 3072353 Review.
Recommendations for an update of the current (2001) regulatory requirements for registration of drugs to be used in the treatment of osteoporosis in postmenopausal women and in men.
Reginster JY, Abadie E, Delmas P, Rizzoli R, Dere W, der Auwera P, Avouac B, Brandi ML, Daifotis A, Diez-Perez A, Calvo G, Johnell O, Kaufman JM, Kreutz G, Laslop A, Lekkerkerker F, Mitlak B, Nilsson P, Orloff J, Smillie M, Taylor A, Tsouderos Y, Ethgen D, Flamion B. Reginster JY, et al. Among authors: avouac b. Osteoporos Int. 2006 Jan;17(1):1-7. doi: 10.1007/s00198-005-1984-3. Epub 2005 Aug 10. Osteoporos Int. 2006. PMID: 16091835
The use of placebo-controlled and non-inferiority trials for the evaluation of new drugs in the treatment of postmenopausal osteoporosis.
Delmas PD, Calvo G, Boers M, Abadie E, Avouac B, Kahan A, Kaufman JM, Laslop A, Lekkerkerker JF, Nilsson P, Van Zwieten-Boot B, Kreutz G, Reginster JY; Group for the Respect of Ethics and Excellence in Science (GREES). Delmas PD, et al. Among authors: avouac b. Osteoporos Int. 2002 Jan;13(1):1-5. doi: 10.1007/s198-002-8331-3. Osteoporos Int. 2002. PMID: 11878450 Review.
Update on the ESCEO recommendation for the conduct of clinical trials for drugs aiming at the treatment of sarcopenia in older adults.
Reginster JY, Beaudart C, Al-Daghri N, Avouac B, Bauer J, Bere N, Bruyère O, Cerreta F, Cesari M, Rosa MM, Cooper C, Cruz Jentoft AJ, Dennison E, Geerinck A, Gielen E, Landi F, Laslop A, Maggi S, Prieto Yerro MC, Rizzoli R, Sundseth H, Sieber C, Trombetti A, Vellas B, Veronese N, Visser M, Vlaskovska M, Fielding RA. Reginster JY, et al. Among authors: avouac b. Aging Clin Exp Res. 2021 Jan;33(1):3-17. doi: 10.1007/s40520-020-01663-4. Epub 2020 Jul 31. Aging Clin Exp Res. 2021. PMID: 32737844 Free PMC article. Review.
101 results